Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
14
BMMJ Quote, Financials, Valuation and Earnings
Last price:
$0.0000
Seasonality move
:
-8.09%
Day range:
$0.0100 - $0.0100
52-week range:
$0.0000 - $0.0219
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.00x
P/B ratio:
--
Volume:
--
Avg. volume:
9.2K
1-year change:
-99.99%
Market cap:
$100
Revenue:
$22.8M
EPS (TTM):
-$0.09
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
BMMJ
Body & Mind, Inc.
|
-- | -- | -- | -- | -- |
|
ATTBF
Abattis Bioceuticals Corp.
|
-- | -- | -- | -- | -- |
|
IMVIF
IMV, Inc.
|
-- | -- | -- | -- | -- |
|
IPCIQ
Intellipharmaceutics International, Inc.
|
-- | -- | -- | -- | -- |
|
NEPTF
Neptune Wellness Solutions, Inc.
|
-- | -- | -- | -- | -- |
|
THCBF
THC Biomed International
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
BMMJ
Body & Mind, Inc.
|
$0.0000 | -- | $100 | -- | $0.00 | 0% | 0.00x |
|
ATTBF
Abattis Bioceuticals Corp.
|
$0.0000 | -- | $500 | -- | $0.00 | 0% | 0.00x |
|
IMVIF
IMV, Inc.
|
$0.0000 | -- | $100 | -- | $0.00 | 0% | 0.00x |
|
IPCIQ
Intellipharmaceutics International, Inc.
|
$0.0000 | -- | -- | -- | $0.00 | 0% | 0.00x |
|
NEPTF
Neptune Wellness Solutions, Inc.
|
$0.0000 | -- | -- | -- | $0.00 | 0% | 0.00x |
|
THCBF
THC Biomed International
|
$0.0000 | -- | -- | -- | $0.00 | 0% | 0.00x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
BMMJ
Body & Mind, Inc.
|
-69.4% | 829.262 | 38.98% | 0.24x |
|
ATTBF
Abattis Bioceuticals Corp.
|
-- | 106.025 | -- | -- |
|
IMVIF
IMV, Inc.
|
-- | 38,821.876 | -- | -- |
|
IPCIQ
Intellipharmaceutics International, Inc.
|
-- | 0.000 | -- | -- |
|
NEPTF
Neptune Wellness Solutions, Inc.
|
-- | -2,397.233 | -- | -- |
|
THCBF
THC Biomed International
|
-- | -1.770 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
BMMJ
Body & Mind, Inc.
|
$2M | -$1.3M | -- | -- | -45.57% | -$1.3M |
|
ATTBF
Abattis Bioceuticals Corp.
|
-- | -- | -- | -- | -- | -- |
|
IMVIF
IMV, Inc.
|
-- | -- | -- | -- | -- | -- |
|
IPCIQ
Intellipharmaceutics International, Inc.
|
-- | -- | -- | -- | -- | -- |
|
NEPTF
Neptune Wellness Solutions, Inc.
|
-- | -- | -- | -- | -- | -- |
|
THCBF
THC Biomed International
|
-- | -- | -- | -- | -- | -- |
Body & Mind, Inc. vs. Competitors
-
Which has Higher Returns BMMJ or ATTBF?
Abattis Bioceuticals Corp. has a net margin of -58.94% compared to Body & Mind, Inc.'s net margin of --. Body & Mind, Inc.'s return on equity of -- beat Abattis Bioceuticals Corp.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMMJBody & Mind, Inc.44.58% -$0.02 -$6.6M ATTBFAbattis Bioceuticals Corp.-- -- -- -
What do Analysts Say About BMMJ or ATTBF?
Body & Mind, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Abattis Bioceuticals Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Body & Mind, Inc. has higher upside potential than Abattis Bioceuticals Corp., analysts believe Body & Mind, Inc. is more attractive than Abattis Bioceuticals Corp..
Company Buy Ratings Hold Ratings Sell Ratings BMMJBody & Mind, Inc.0 0 0 ATTBFAbattis Bioceuticals Corp.0 0 0 -
Is BMMJ or ATTBF More Risky?
Body & Mind, Inc. has a beta of 85.249, which suggesting that the stock is 8424.895% more volatile than S&P 500. In comparison Abattis Bioceuticals Corp. has a beta of -54.237, suggesting its less volatile than the S&P 500 by 5523.68%.
-
Which is a Better Dividend Stock BMMJ or ATTBF?
Body & Mind, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Abattis Bioceuticals Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Body & Mind, Inc. pays -- of its earnings as a dividend. Abattis Bioceuticals Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BMMJ or ATTBF?
Body & Mind, Inc. quarterly revenues are $4.4M, which are larger than Abattis Bioceuticals Corp. quarterly revenues of --. Body & Mind, Inc.'s net income of -$2.6M is higher than Abattis Bioceuticals Corp.'s net income of --. Notably, Body & Mind, Inc.'s price-to-earnings ratio is -- while Abattis Bioceuticals Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Body & Mind, Inc. is 0.00x versus 0.00x for Abattis Bioceuticals Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMMJBody & Mind, Inc.0.00x -- $4.4M -$2.6M ATTBFAbattis Bioceuticals Corp.0.00x -- -- --
-
Which has Higher Returns BMMJ or IMVIF?
IMV, Inc. has a net margin of -58.94% compared to Body & Mind, Inc.'s net margin of --. Body & Mind, Inc.'s return on equity of -- beat IMV, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMMJBody & Mind, Inc.44.58% -$0.02 -$6.6M IMVIFIMV, Inc.-- -- -- -
What do Analysts Say About BMMJ or IMVIF?
Body & Mind, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand IMV, Inc. has an analysts' consensus of -- which suggests that it could grow by 60026549%. Given that IMV, Inc. has higher upside potential than Body & Mind, Inc., analysts believe IMV, Inc. is more attractive than Body & Mind, Inc..
Company Buy Ratings Hold Ratings Sell Ratings BMMJBody & Mind, Inc.0 0 0 IMVIFIMV, Inc.0 0 0 -
Is BMMJ or IMVIF More Risky?
Body & Mind, Inc. has a beta of 85.249, which suggesting that the stock is 8424.895% more volatile than S&P 500. In comparison IMV, Inc. has a beta of 4,163.175, suggesting its more volatile than the S&P 500 by 416217.536%.
-
Which is a Better Dividend Stock BMMJ or IMVIF?
Body & Mind, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IMV, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Body & Mind, Inc. pays -- of its earnings as a dividend. IMV, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BMMJ or IMVIF?
Body & Mind, Inc. quarterly revenues are $4.4M, which are larger than IMV, Inc. quarterly revenues of --. Body & Mind, Inc.'s net income of -$2.6M is higher than IMV, Inc.'s net income of --. Notably, Body & Mind, Inc.'s price-to-earnings ratio is -- while IMV, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Body & Mind, Inc. is 0.00x versus 0.00x for IMV, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMMJBody & Mind, Inc.0.00x -- $4.4M -$2.6M IMVIFIMV, Inc.0.00x -- -- --
-
Which has Higher Returns BMMJ or IPCIQ?
Intellipharmaceutics International, Inc. has a net margin of -58.94% compared to Body & Mind, Inc.'s net margin of --. Body & Mind, Inc.'s return on equity of -- beat Intellipharmaceutics International, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMMJBody & Mind, Inc.44.58% -$0.02 -$6.6M IPCIQIntellipharmaceutics International, Inc.-- -- -- -
What do Analysts Say About BMMJ or IPCIQ?
Body & Mind, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Intellipharmaceutics International, Inc. has an analysts' consensus of -- which suggests that it could grow by 41566.67%. Given that Intellipharmaceutics International, Inc. has higher upside potential than Body & Mind, Inc., analysts believe Intellipharmaceutics International, Inc. is more attractive than Body & Mind, Inc..
Company Buy Ratings Hold Ratings Sell Ratings BMMJBody & Mind, Inc.0 0 0 IPCIQIntellipharmaceutics International, Inc.0 0 0 -
Is BMMJ or IPCIQ More Risky?
Body & Mind, Inc. has a beta of 85.249, which suggesting that the stock is 8424.895% more volatile than S&P 500. In comparison Intellipharmaceutics International, Inc. has a beta of 1.405, suggesting its more volatile than the S&P 500 by 40.548%.
-
Which is a Better Dividend Stock BMMJ or IPCIQ?
Body & Mind, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intellipharmaceutics International, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Body & Mind, Inc. pays -- of its earnings as a dividend. Intellipharmaceutics International, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BMMJ or IPCIQ?
Body & Mind, Inc. quarterly revenues are $4.4M, which are larger than Intellipharmaceutics International, Inc. quarterly revenues of --. Body & Mind, Inc.'s net income of -$2.6M is higher than Intellipharmaceutics International, Inc.'s net income of --. Notably, Body & Mind, Inc.'s price-to-earnings ratio is -- while Intellipharmaceutics International, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Body & Mind, Inc. is 0.00x versus 0.00x for Intellipharmaceutics International, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMMJBody & Mind, Inc.0.00x -- $4.4M -$2.6M IPCIQIntellipharmaceutics International, Inc.0.00x -- -- --
-
Which has Higher Returns BMMJ or NEPTF?
Neptune Wellness Solutions, Inc. has a net margin of -58.94% compared to Body & Mind, Inc.'s net margin of --. Body & Mind, Inc.'s return on equity of -- beat Neptune Wellness Solutions, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMMJBody & Mind, Inc.44.58% -$0.02 -$6.6M NEPTFNeptune Wellness Solutions, Inc.-- -- -- -
What do Analysts Say About BMMJ or NEPTF?
Body & Mind, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Neptune Wellness Solutions, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Body & Mind, Inc. has higher upside potential than Neptune Wellness Solutions, Inc., analysts believe Body & Mind, Inc. is more attractive than Neptune Wellness Solutions, Inc..
Company Buy Ratings Hold Ratings Sell Ratings BMMJBody & Mind, Inc.0 0 0 NEPTFNeptune Wellness Solutions, Inc.0 0 0 -
Is BMMJ or NEPTF More Risky?
Body & Mind, Inc. has a beta of 85.249, which suggesting that the stock is 8424.895% more volatile than S&P 500. In comparison Neptune Wellness Solutions, Inc. has a beta of -508.383, suggesting its less volatile than the S&P 500 by 50938.254%.
-
Which is a Better Dividend Stock BMMJ or NEPTF?
Body & Mind, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Neptune Wellness Solutions, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Body & Mind, Inc. pays -- of its earnings as a dividend. Neptune Wellness Solutions, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BMMJ or NEPTF?
Body & Mind, Inc. quarterly revenues are $4.4M, which are larger than Neptune Wellness Solutions, Inc. quarterly revenues of --. Body & Mind, Inc.'s net income of -$2.6M is higher than Neptune Wellness Solutions, Inc.'s net income of --. Notably, Body & Mind, Inc.'s price-to-earnings ratio is -- while Neptune Wellness Solutions, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Body & Mind, Inc. is 0.00x versus 0.00x for Neptune Wellness Solutions, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMMJBody & Mind, Inc.0.00x -- $4.4M -$2.6M NEPTFNeptune Wellness Solutions, Inc.0.00x -- -- --
-
Which has Higher Returns BMMJ or THCBF?
THC Biomed International has a net margin of -58.94% compared to Body & Mind, Inc.'s net margin of --. Body & Mind, Inc.'s return on equity of -- beat THC Biomed International's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BMMJBody & Mind, Inc.44.58% -$0.02 -$6.6M THCBFTHC Biomed International-- -- -- -
What do Analysts Say About BMMJ or THCBF?
Body & Mind, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand THC Biomed International has an analysts' consensus of -- which suggests that it could fall by --. Given that Body & Mind, Inc. has higher upside potential than THC Biomed International, analysts believe Body & Mind, Inc. is more attractive than THC Biomed International.
Company Buy Ratings Hold Ratings Sell Ratings BMMJBody & Mind, Inc.0 0 0 THCBFTHC Biomed International0 0 0 -
Is BMMJ or THCBF More Risky?
Body & Mind, Inc. has a beta of 85.249, which suggesting that the stock is 8424.895% more volatile than S&P 500. In comparison THC Biomed International has a beta of 0.223, suggesting its less volatile than the S&P 500 by 77.711%.
-
Which is a Better Dividend Stock BMMJ or THCBF?
Body & Mind, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. THC Biomed International offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Body & Mind, Inc. pays -- of its earnings as a dividend. THC Biomed International pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BMMJ or THCBF?
Body & Mind, Inc. quarterly revenues are $4.4M, which are larger than THC Biomed International quarterly revenues of --. Body & Mind, Inc.'s net income of -$2.6M is higher than THC Biomed International's net income of --. Notably, Body & Mind, Inc.'s price-to-earnings ratio is -- while THC Biomed International's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Body & Mind, Inc. is 0.00x versus 0.00x for THC Biomed International. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BMMJBody & Mind, Inc.0.00x -- $4.4M -$2.6M THCBFTHC Biomed International0.00x -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
